Nuveen’s Akero Therapeutics AKRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-164,529
| Closed | -$7.81M | – | 3251 |
|
|
2025
Q3 | $7.81M | Sell |
164,529
-202,240
| -55% | -$9.79M | ﹤0.01% | 1692 |
|
|
2025
Q2 | $19.6M | Buy |
366,769
+58,443
| +19% | +$2.66M | 0.01% | 1111 |
|
|
2025
Q1 | $1.67M | Buy |
308,326
+136,808
| +80% | +$5.8M | ﹤0.01% | 2413 |
|
|
2024
Q4 | $4.77M | Sell |
171,518
-3,385
| -2% | -$103K | ﹤0.01% | 2007 |
|
|
2024
Q3 | $5.02M | Hold |
174,903
| – | – | ﹤0.01% | 1985 |
|
|
2024
Q2 | $4.1M | Buy |
174,903
+30,040
| +21% | +$642K | ﹤0.01% | 2051 |
|
|
2024
Q1 | $3.66M | Buy |
144,863
+12,722
| +10% | +$306K | ﹤0.01% | 2128 |
|
|
2023
Q4 | $3.09M | Buy |
132,141
+658
| +0.5% | +$13K | ﹤0.01% | 2211 |
|
|
2023
Q3 | $6.65M | Buy |
131,483
+7,591
| +6% | +$353K | ﹤0.01% | 1719 |
|
|
2023
Q2 | $5.78M | Buy |
123,892
+31,513
| +34% | +$1.44M | ﹤0.01% | 1835 |
|
|
2023
Q1 | $3.53M | Sell |
92,379
-8,139
| -8% | -$363K | ﹤0.01% | 2079 |
|
|
2022
Q4 | $1.23M | Sell |
100,518
-31,727
| -24% | -$1.36M | ﹤0.01% | 2599 |
|
|
2022
Q3 | $1.62M | Buy |
132,245
+34,800
| +36% | +$532K | ﹤0.01% | 2510 |
|
|
2022
Q2 | $921K | Buy |
97,445
+13,880
| +17% | +$145K | ﹤0.01% | 2821 |
|
|
2022
Q1 | $1.2M | Buy |
83,565
+936
| +1% | +$16.4K | ﹤0.01% | 2742 |
|
|
2021
Q4 | $1.62M | Sell |
82,629
-6,311
| -7% | -$140K | ﹤0.01% | 2666 |
|
|
2021
Q3 | $2.21M | Sell |
88,940
-5,384
| -6% | -$122K | ﹤0.01% | 2622 |
|
|
2021
Q2 | $2.34M | Buy |
94,324
+43,958
| +87% | +$1.23M | ﹤0.01% | 2632 |
|
|
2021
Q1 | $1.46M | Sell |
50,366
-939
| -2% | -$28.4K | ﹤0.01% | 2756 |
|
|
2020
Q4 | $1.32M | Sell |
51,305
-17,519
| -25% | -$487K | ﹤0.01% | 2696 |
|
|
2020
Q3 | $2.12M | Buy |
68,824
+24,133
| +54% | +$843K | ﹤0.01% | 2354 |
|
|
2020
Q2 | $1.11M | Buy |
44,691
+26,915
| +151% | +$615K | ﹤0.01% | 2580 |
|
|
2020
Q1 | $377K | Buy |
+17,776
| New | +$381K | ﹤0.01% | 2867 |
|
Other funds holding AKRO
Nuveen's AKRO Position: Q4 2025 in Review
Nuveen sold out of Akero Therapeutics (AKRO) in Q4 2025, closing a stake of 164,529 shares — an estimated $7.81M sold.
Nuveen first reported a position in AKRO in Q1 2020 and held it in 23 quarters. The position peaked at $19.6M in Q2 2025. 2 funds tracked by Wall St. Rank hold AKRO as of Q4 2025.
- Nuveen reported no remaining Akero Therapeutics position as of Q4 2025 after selling out during the quarter.
- Nuveen sold 164,529 Akero Therapeutics shares in Q4 2025, an estimated $7.81M.
- Nuveen first reported a position in Akero Therapeutics in Q1 2020 and held it in 23 quarters.
- Nuveen's Akero Therapeutics position peaked at $19.6M in Q2 2025.
- 2 funds tracked by Wall St. Rank held Akero Therapeutics as of Q4 2025.
Based on Nuveen's 13F filing for Q4 2025, filed 12 Feb 2026.